Ironwood Pharmaceuticals plans to align with the FDA regarding the design of its clinical trials.

The entities involved

• FDA →
  • The FDA is involved in regulating drug approvals for GLP-1 Receptor Agonists.13:39
  • FDA accepted Axion BioSystems' Letter of Intent (LOI) for a neural assay on November 10, 2026.11:05
• Ironwood Pharmaceuticals →

  company in Cambridge, United States

  • Analyst upgraded Ironwood Pharmaceuticals to 'hold' rating, concurrent with insider selling disclosures filed with the SEC.Tue 09:51

Related events

• FDA approval is the goal for product candidates from Daré Bioscience, Inc.Jun 7
• FDA approved a medical device from Abbott and supported a PARADIGM study based on data from the Cleveland Clinic.Oct 28
• InflaRx is seeking discussions with the FDA and collaborating with Staidson BioPharmaceuticals on clinical trials.Nov 3
• An AI-designed drug is currently in trials, prompting a focus on global legal and ethical standards.Jun 30
• Merck announced on September 3, 2025, that it is seeking potential approval for new drugs from the FDA.Jun 7